Interaction between protein tyrosine phosphatase and protein tyrosine kinase is involved in androgen-promoted growth of human prostate cancer cells

Oncogene

Volumn 19, Issue 22, 2000, Pages 2664-2677

  Meng, Tzu Ching ^a,c   Lee, Ming Shyue ^a   Lin, Ming Fong ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c WM Keck Structural Biology Laboratory   (United States)

Author keywords

Androgen responsiveness; ErbB 2; Human prostate cancer; Prostatic acid phosphatase; Tyrosine phosphorylation

Indexed keywords

ACID PHOSPHATASE; ANDROGEN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOTYROSINE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE; STEROID HORMONE; STEROID RECEPTOR;

ADVANCED CANCER; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

EID: 0034682240     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203576     Document Type: Article

References (90)

1. Arai Y, Yoshiki T and Yoshida O. (1997). Prostate, 30, 195-201.
2. Bacus SS, Chin D, Yarden Y, Zelnick CR and Stern DF. (1996). Am. J. Pathol., 148, 549-558.
3. Bagchi MK, Tsai MJ, O'Malley BW and Tsai SY. (1992). Endocr. Rev., 13, 525-535.
4. Beato M. (1989). Cell, 56, 335-344.
5. Beato M and Sanchez Pacheco A. (1996). Endocr. Rev., 17, 587-609.
6. Beerli RR and Hynes NE. (1996). J. Biol. Chem., 271, 6071-6076.
7. Ben-Levy R, Paterson HF, Marshall CJ and Yarden Y. (1994). EMBO J., 13, 3302-3311.
8. Brass AL, Barnard J, Patai BL, Salvi D and Rukstalis DB. (1995). Cancer Res., 55, 3197-3203.
9. Cantley LC, Auger KR, Carpenter C, Duckworth B, Graziani A, Kapeller R and Soltoff S. (1991). Cell, 64, 281-302.
10. Craft N, Shostak Y, Carey M and Saywers CL. (1999). Nature Med., 5, 280-285.
11. Cross M and Dexter TM. (1991). Cell, 64, 271-280.
12. de Winter JA, Trapman J, Brinkmann AO, Boersma WJ, Mulder E, Schroeder FH, Claassen E and van der Kwast TH. (1990). J. Pathol., 160, 329-332.
13. Dickson RB and Lippman ME. (1987). Endocr. Rev., 8, 29-43.
14. Di Fiore PP, Pierce JH, Fleming TP, Hazan R, Ullrich A, King CR, Schlessinger J and Aaronson SA. (1987). Cell, 51, 1063-1070.
15. Diamond DA and Barrack ER. (1984). J. Urol., 132, 821-827.
16. Evan GI, Lewis GK, Ramsay G and Bishop M. (1985). Mol. Cell. Biol., 5, 3610-3616.
17. Fanger BO, Viceps Madore D and Cidlowski JA. (1984). Arch. Biochem. Biophys., 235, 141-149.
18. Foti AG, Herschman H and Cooper JF. (1977). Cancer Res., 37, 4120-4124.
19. Gioeli D, Mandell JW, Petroni GR, Frierson Jr HF and Weber MJ. (1999). Cancer Res., 59, 279-284.
20. Gittes RF. (1991). N. Engl. J. Med., 324, 236-245.
21. Glauber JG and Kiang DT. (1992). Semin. Oncol., 19, 308-316.
22. Grasso AW, Wen D, Miller CM, Rhim JS, Pretlow TG and Kung HJ. (1997). Oncogene, 15, 2705-2716.
23. Graus Porta D, Beerli RR, Daly JM and Hynes NE. (1997). EMBO J., 16, 1647-1655.
24. Grayhack JT, Keeler TC and Kozlowski JM. (1987). Cancer, 60, 589-601.
25. Gu K, Mes Masson AM, Gauthier J and Saad F. (1996). Cancer Lett., 99, 185-189.
26. Guy PM, Platko JV, Cantley LC, Cerione RA and Carraway III KL. (1994). Proc. Natl. Acad. Sci. USA, 91, 8132-8136.
27. Harris JR, Lippman ME, Veronesi U and Willett W. (1992). N. Engl. J. Med., 327, 473-480.
28. Horwitz KB. (1992). Endocr. Rev., 13, 146-163.
29. Hua W, Christianson T, Rougeot C, Rochefort H and Clinton GM. (1995). J. Steroid. Biochem. Mol. Biol., 55, 279-289.
30. Hudziak RM, Schlessinger J and Ullrich A. (1987). Proc. Natl. Acad. Sci. USA, 84, 7159-7163.
31. Hunter T. (1995). Cell, 80, 225-236.
32. Hunter T and Sefton BM. (1980). Proc. Natl. Acad. Sci. USA, 77, 1311-1315.
33. Hynes NE and Stern DF. (1994). Biochim. Biophys. Acta. 1198, 165-184.
34. Isaacs JT. (1982). Cancer Res., 42, 5010-5014.
35. Janes PW, Daly RJ, deFazio A, Sutherland RL. (1994). Oncogene, 9, 3601-3608.
36. Jensen EV. (1991). Curr. Top. Pathol., 83, 365-431.
37. Kallio PJ, Janne OA and Palvimo JJ. (1994). Endocrinology, 134, 998-1001.
38. Kuhn EJ, Kurnot RA, Sesterhenn IA, Chang EH and Moul JW. (1993). J. Urol., 150, 1427-1433.
39. Latil A, Baron JC, Cussenot O, Fournier G, Boccon Gibod L, Le Duc A and Lidercau R. (1994). Int. J. Cancer, 59, 637-638.
40. Levitzki A and Gazit A. (1995). Science, 267, 1782-1788.
41. Li HC, Chernoff J, Chen LB and Kirschonbaum A. (1984). Eur. J. Biochem., 138, 45-51.
42. Lin MF and Clinton GM. (1986). Biochem. J., 235, 351-357.
43. Lin MF, Lee CL and Clinton GM. (1986). Mol. Cell. Biol., 6, 4753-4757.
44. Lin MF and Clinton GM. (1987). Adv. Protein Phosphatases, 4, 199-228.
45. Lin MF and Clinton GM. (1988). Mol. Cell. Biol., 8, 5477-5485.
46. Lin MF, DaVolio J and Garcia Arenas R. (1992). Cancer Res., 52, 4600-4607.
47. Lin MF, Garcia-Arenas R, Chao YC, Lai MM, Patel PC and Xia XZ. (1993). Arch. Biochem. Biophys., 300, 384-390.
48. Lin MF and Meng TC. (1996). Biochem. Biophys. Res. Commun., 226, 206-213.
49. Lin MF, Meng TC, Rao PS, Chang C, Schonthal AH and Lin FF. (1998). J. Biol. Chem., 273, 5939-5947.
50. Lin MF, Lee MS, Garcia-Arenas R and Lin FF. (2000). Cell Biol. Int., (in press).
51. Li u XH, Wiley HS and Meikle AW. (1993). J. Clin. Endocrinol. Metab., 77, 1472-1478.
52. Loor R, Wang MC, Valenzuela L and Chu TM. (1981). Cancer Lett., 14, 63-69.
53. Lu S, Tsai SY and Tsai MJ. (1997). Cancer Res., 57, 4511-4516.
54. Macoska JA, Powell IJ, Sakr W and Lane MA. (1992). J. Urol., 147, 1142-1146.
55. Marengo SR, Sikes RA, Anezinis P, Chang SM and Chung LW. (1997). Mol. Carcinog., 19, 165-175.
56. Meng TC and Lin MF. (1998). J. Biol. Chem., 273, 22096-22104.
57. Miller JI, Ahmann FR, Drach GW, Emerson SS and Bottaccini MR. (1992). J. Urol., 147, 956-961.
58. Murphy LJ, Sutherland RL, Stead B, Murphy LC and Lazarus L. (1986). Cancer Res., 46, 728-734.
59. Nicholson S, Wright C, Sainsbury JR, Halcrow P, Kelly P, Angus B, Farndon JR and Harris AL. (1990). J. Steroid. Biochem. Mol. Biol., 37, 811-814.
60. Pietras RJ, Arboleda J, Reese DM, Wongvipat N, Pegram MD, Ramos L, Gorman CM, Parker MG, Sliwkowski MX and Slamon DJ. (1995). Oncogene, 10, 2435-2446.
61. Plowman GD, Green JM, Culouscou JM, Carlton GW, Rothwell VM and Buckley S. (1993). Nature, 366, 473-475.
62. Press MF, Pike MC, Chazin VR, Hung G, Udove JA, Markowicz M, Danyluk J, Godolphin W, Sliwkowski M, Akita R, Paterson MC and Slamon DJ. (1993). Cancer Res., 53, 4960-4970.
63. Qiu Y, Ravi L and Kung HJ. (1998). Nature, 393, 83-85.
64. Quarmby VE, Beckman Jr WC, Cooke DB, Lubahn DB, Joseph DR, Wilson EM and French FS. (1990). Cancer Res., 50, 735-739.
65. Quigley CA, De Bellis A, Marschke KB, el Awady MK, Wilson EM and French FS. (1995). Endocr. Rev., 16, 271-321.
66. Reif AE, Schlesinger RM, Fish CA and Robinson CM. (1973). Cancer, 31, 689-699.
67. Riese DJ, Kim ED, Elenius K, Buckley S, Klagsbrun M, Plowman GD and Stern DF. (1996). J. Biol. Chem., 271, 20047-20052.
68. Robinson D, He F, Pretlow T and Kung HJ. (1996). Proc. Natl. Acad. Sci. USA, 93, 5958-5962.
69. Sadasivan R, Morgan R, Jennings S, Austenfeld M, Van Veldhuizen P, Stephens R and Noble M. (1993). J. Urol., 150, 126-131.
70. Sadi MV and Barrack ER. (1993). Cancer, 71, 2574-2580.
71. Sandberg AA and Kadohama N. (1980). Prog. Clin. Biol. Res., 37, 9-29.
72. Schneider G, Lindqvist Y and Vihko P. (1993). EMBO J., 12, 2609-2615.
73. Schuurmans AL, Bolt J, Veldscholte J and Mulder E. (1991). J. Steroid. Biochem. Mol. Biol., 40, 193-197.
74. Scott WW, Menon M and Walsh PC. (1980). Cancer. 45, 1929-1936.
75. Sherwood ER, Van Dongen JL, Wood CG, Liao S, Kozlowski JM and Lee C. (1998). Br. J. Cancer, 77, 855-861.
76. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A and Press MF. (1989). Science, 244, 707-712.
77. Sliwkowski MX, Schaefer G, Akita RW, Lofgren JA, Fitzpatrick VD, Nuijens A, Fendly BM, Cerione RA, Vandlen RL and Carraway III KL. (1994). J. Biol. Chem., 269, 14661-14665.
78. Stamey TA, Kabalin JN, Ferrari M and Yang N. (1989). J. Urol., 141, 1088-1090.
79. Strohmeyer TG and Slamon DJ. (1994). J. Urol., 151, 1479-1497.
80. Taplin ME, Bubley GJ, Shuster TD, Frantz ME, Spooner AE, Ogata GK, Keer HN and Balk SP. (1995). N. Engl. J. Med., 332, 1393-1398.
81. Tenniswood M. (1986). Prostate, 9, 375-385.
82. Tjian R and Maniatis T. (1994), Cell, 77, 5-8.
83. van der Kwast TH, Schalken J, Ruizeveld de Winter JA, van Vroonhoven CC, Mulder E, Boersma W and Trapman J. (1991). Int. J. Cancer, 48, 189-193.
84. Weiss C, Ho AD, Hiller E, Thiel E, Schlag R, Lipp T, Herrmann R, Musch E, Termander B and Hunstein W. (1990). Leuk. Res., 14, 327-332.
85. Wright C, Prasad K and Lennard TJ. (1992). J. Clin. Pathol., 45, 459-460.
86. Yam LT. (1974). Am. J. Med., 56, 604-616.
87. Yan G, Fukabori Y, Nikolaropoulos S, Wang F and McKeehan WL. (1992). Mol. Endocrinol., 6, 2123-2128.
88. Yeh S, Lin HK, Kang HY, Thin TH, Lin MF and Chang C. (1999). Proc. Natl. Acad. Sci. USA, 96, 5458-5463.
89. Yuan S, Trachtenberg J, Mills GB, Brown TJ, Xu F and Renting A. (1993). Cancer Res., 53, 1304-1311.
90. Zelivianski S, Comeau D and Lin MF. (1998). Biochem. Biophys. Res. Commun., 245, 108-112.